Why the study?
Does the presence of corneal arcus predict mortality from coronary heart disease and cardiovascular disease in adults without baseline CHD?
Does the presence of corneal arcus predict mortality from coronary heart disease and cardiovascular disease in adults without baseline CHD?
Corneal arcus is an independent prognostic factor for CHD and CVD mortality in young hyperlipidemic men (ages 30-49), providing a useful physical examination marker for clinical risk stratification.
The relationship between corneal arcus (arcus senilis) and mortality from coronary heart disease (CHD) and cardiovascular disease (CVD) is examined in a prospective study of White men (n = 3,930) and women non-hormone users (n = 2,139), ages 30-69, followed for an average of 8.4 years as part of the Lipid Research Clinics Mortality Follow-up Study. After excluding those with clinically manifest CHD at baseline, corneal arcus was strongly associated with CHD and CVD mortality only in hyperlipidemic men ages 30-49 years, for whom the relative risk for CHD and CVD death was 3.7 and 4.0, respectively, after adjusting for age, total cholesterol, HDL cholesterol, and smoking status using a Cox proportional hazards model. Among 30-49 year old males, corneal arcus appears to be a prognostic factor for CHD, independent of its association with hyperlipidemia in this age-group, of about the same magnitude as other common risk factors, underscoring the usefulness of corneal arcus as a prognostic factor to the practicing clinician.
No takes yet. Share an insight, caveat, or question.
Chambless et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: